2,115 results on '"Hibi, T"'
Search Results
2. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
3. P568 Clinical relevance of baseline and change in Urgency Numeric Rating Scale score for mirikizumab treatment for Ulcerative Colitis
4. P922 A multicenter retrospective real-world study to determine the optimal cases of vedolizumab-treated UC patients
5. P687 Ozanimod as a once-daily oral therapy for Japanese patients with ulcerative colitis: results from the induction period of a Phase 2/3 study (J-True North)
6. P482 Diagnostic accuracy of contrast-enhanced ultrasound for fibrotic strictures of Crohn’s disease: a systematic review and meta-analysis of individual participant data
7. P283 Efficacy and safety of etrasimod in patients with moderately to severely active UC in Japan: Integrated analysis of the phase 3 ELEVATE UC 12 and ELEVATE UC 40 JAPAN trials
8. DOP70 Prevalence and severity of bowel urgency in Crohn’s Disease: Results from the Communicating Needs and Features of IBD Experience (CONFIDE) Survey
9. P285 Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: European and US Patient and Health Care Professional Perspectives on the Broad Impact of Bowel Urgency in Ulcerative colitis
10. P816 Baseline disease severity of patients with Ulcerative Colitis influences rapid symptom relief under filgotinib treatment: post hoc analysis of the phase 2b/3 SELECTION study
11. A190 THE IMPACT OF BOWEL URGENCY ON THE LIVES OF PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
12. A216 BOWEL URGENCY COMMUNICATION GAP BETWEEN HEALTH CARE PROFESSIONALS AND PATIENTS WITH ULCERATIVE COLITIS IN THE US AND EUROPE: COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY
13. A201 EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS FROM THE PHASE 3 LUCENT INDUCTION AND MAINTENANCE STUDIES
14. A186 ASSOCIATION OF ULCERATIVE COLITIS BOWEL URGENCY IMPROVEMENT WITH CLINICAL RESPONSE AND REMISSION
15. P597 Usefulness of histological monitoring in predicting relapse after de-escalation of thiopurines in Ulcerative Colitis
16. P507 United States and European patient perspectives on the impact of moderate-to-severe Ulcerative Colitis on sexual activity: Communicating Needs and Features of IBD Experiences (CONFIDE) survey
17. P388 Shear wave elastography predicts short-term response to induction therapy in patients with Crohn’s disease
18. P594 Bowel ultrasound is useful in predicting relapse in patients with Ulcerative Colitis in remission
19. P743 Relative association of bowel urgency improvement versus remission of stool frequency and rectal bleeding with Patient Global Rating of Severity or Change scores in moderately-to-severely active Ulcerative Colitis: An analysis from the LUCENT-1 and LUCENT-2 Phase 3 trials
20. DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE
21. P094 Impacts of 5-aminosalicylic acid on the intestinal microbiota leading to the anti-inflammatory effect
22. P319 Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
23. Development and Validation of Prediction Models for Post-hepatectomy Liver Failure and Postoperative Complications Using an International Cohort of Major Hepatectomies
24. DOP056 Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn’s disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study
25. H-dibaryon search by KEK-E522 : Search for the ΛΛ resonance in 12C (K−, K+ΛΛX) using a scintillating fiber active target
26. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
27. Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases:an International Organization for Study of Inflammatory Bowel Diseases consensus
28. Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohnʼs disease: a subanalysis of the DIAMOND trial
29. P523 Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohnʼs disease: a subanalysis of DIAMOND trial
30. P493 Efficacy of anti-TNF for internal fistula in Crohnʼs disease – results from a retrospective multicenter cohort study
31. P325 Combination therapy with adalimumab and immunomodulators decreases incidence of intestinal resection in Crohnʼs disease patients previously treated with infliximab: a large, multicentre cohort study
32. P293 Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healing
33. P215 Clinical features of chronic enteropathy associated with SLCO2A1 gene (CEAS)
34. DOP073 Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease
35. DOP071 Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohnʼs disease: a sub-analysis of DIAMOND trial
36. Citrulline Level Is a Potent Indicator of Acute Rejection in the Long Term Following Pediatric Intestinal/Multivisceral Transplantation
37. Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation
38. Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection
39. Advantages of Extrahepatic Glissonean Approach in the Donor Operation in Living Donor Liver Transplantation
40. Hepatic Venous Outflow Obstruction after Adult Living Donor Liver Transplantation
41. P497 Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis
42. Demystifying Post-hepatectomy Enzyme Kinetics for the Surgical Learner: An Analysis of 989 Major Hepatectomies
43. Elevated Alfa-Fetoprotein Levels and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes after Liver Transplantation for Hepatocellular Carcinoma Beyond the New Japan Criteria
44. Using Machine Learning to Predict Post-Hepatectomy Liver Failure and Postoperative Complications in an International Cohort of Major Hepatectomies
45. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn
46. Associations of HLA class I alleles in Japanese patients with Crohn’s disease
47. Altered mucosal immune response in CCl4-induced liver cirrhotic rats
48. Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study
49. Efficacy and Safety of Filgotinib as Induction Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study
50. Chitin oligosaccharide binding protein
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.